AN RISING MENACE TO SOCIETY: A CASE SERIES ON IDIOPATHIC INTRACRANIAL HYPERTENSION

SANJAYKUMAR RATHWA; PRATIKSHA  RATHWA; VRUSHABH NIRGUDE; VRUSHABH Nirgude

doi:10.22159/ijcpr.2025v17i4.7009

Authors

SANJAYKUMAR RATHWA Department of Medicine, SBKS Medical Institute and Research Centre, Sumandeep Vidyapeeth Deemed to be University, Pipariya, Vadodara, Gujrat, India https://orcid.org/0009-0008-9241-8477
PRATIKSHA RATHWA Department of Dermatology Venereology and Leprosy, SBKS Medical Institute and Research Centre, Sumandeep Vidyapeeth Deemed to be University, Pipariya, Vadodara, Gujrat, India https://orcid.org/0009-0007-1746-8303
VRUSHABH NIRGUDE Department of Medicine, SBKS Medical Institute and Research Centre, Sumandeep Vidyapeeth Deemed to be University, Pipariya, Vadodara, Gujrat, India https://orcid.org/0009-0003-3490-5668
VRUSHABH NIRGUDE

DOI:

https://doi.org/10.22159/ijcpr.2025v17i4.7009

Keywords:

Idiopathic Intracranial Hypertension, Papilledema, High intracranial pressure, Acetazolamide, Headache, Pseudotumour Cerebri

Abstract

Idiopathic intracranial hypertension (IIH) is a complex neurological disorder characterized by elevated intracranial pressure. This case series examines the clinical manifestations and therapeutic management of IIH. The patients presented with headache, visual disturbances, and diplopia, with the latter symptom attributed to abducens nerve palsy. Our findings highlight the importance of prompt recognition and treatment of IIH, as delayed diagnosis can lead to irreversible visual loss and other complications. This case series provides valuable insights into the presentation and management of IIH, emphasizing the need for increased awareness and vigilance among healthcare providers.

Downloads

Download data is not yet available.

Author Biography

VRUSHABH NIRGUDE

DEPARTMENT OF MEDICINE, SBKS MEDICAL INSTITUTE AND RESEARCH CENTRE, SUMANDEEP VIDYAPEETH DEEMED TO BE UNIVERSITY, PIPARIYA, VADODARA

References

1. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492-5. doi: 10.1212/01.wnl.0000029570.69134.1b, PMID 12455560.

2. Wall M. Idiopathic intracranial hypertension. Neurol Clin. 2010;28(3):593-617. doi: 10.1016/j.ncl.2010.03.003, PMID 20637991.

3. Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia. 2006;26(4):384-99. doi: 10.1111/j.1468-2982.2005.01055.x, PMID 16556239.

4. Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurologist. 2001;7(1):2-68. doi: 10.1097/00127893-200107010-00002.

5. Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology and case control study. Neurology. 1993;43(4):868-74.

6. Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri) descriptive epidemiology in rochester minn 1976 to 1990. Arch Neurol. 1993;50(1):78-80. doi: 10.1001/archneur.1993.00540010072020, PMID 8418804.

7. Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ. Profiles of obesity weight gain and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143(4):635-41. doi: 10.1016/j.ajo.2006.12.040, PMID 17386271.

8. Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS. Visual loss in pseudotumor cerebri follow up of 57 patients from five to 41 Y and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39(8):461-74. doi: 10.1001/archneur.1982.00510200003001, PMID 7103794.

9. Corbett JJ. The 1982 silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci. 1983;10(4):221-9. doi: 10.1017/s0317167100045042, PMID 6652584.

10. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159-65. doi: 10.1212/WNL.0b013e3182a55f17, PMID 23966248.

11. Brodsky MC, Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology. 1998;105(9):1686-93. doi: 10.1016/S0161-6420(98)99039-X, PMID 9754178.

12. Piper RJ, Kalyvas AV, Young AM, Hughes MA, Jamjoom AA, Fouyas IP. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev. 2015;2015(8):CD003434. doi: 10.1002/14651858.CD003434.pub3, PMID 26250102.

13. Rosenberg ML, Corbett JJ, Smith C, Goodwin J, Sergott R, Savino P. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology. 1993;43(6):1071-2. doi: 10.1212/wnl.43.6.1071, PMID 8170543.

14. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996;46(6):1524-30. doi: 10.1212/wnl.46.6.1524, PMID 8649541.